- Home
- PYPD vs MKZR Comparison
PYPD vs MKZR Comparison
Compare PYPD & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- MKZR
- Stock Information
- Founded
- PYPD 2008
- MKZR 2012
- Country
- PYPD Israel
- MKZR United States
- Employees
- PYPD N/A
- MKZR N/A
- Industry
- PYPD Medical/Dental Instruments
- MKZR
- Sector
- PYPD Health Care
- MKZR
- Exchange
- PYPD Nasdaq
- MKZR Nasdaq
- Market Cap
- PYPD 25.0M
- MKZR 26.8M
- IPO Year
- PYPD 2020
- MKZR N/A
- Fundamental
- Price
- PYPD $2.66
- MKZR $1.16
- Analyst Decision
- PYPD Strong Buy
- MKZR
- Analyst Count
- PYPD 2
- MKZR 0
- Target Price
- PYPD $10.50
- MKZR N/A
- AVG Volume (30 Days)
- PYPD 10.9K
- MKZR 33.7K
- Earning Date
- PYPD 05-07-2025
- MKZR 01-01-0001
- Dividend Yield
- PYPD N/A
- MKZR 17.39%
- EPS Growth
- PYPD N/A
- MKZR N/A
- EPS
- PYPD N/A
- MKZR N/A
- Revenue
- PYPD N/A
- MKZR $23,087,751.00
- Revenue This Year
- PYPD N/A
- MKZR N/A
- Revenue Next Year
- PYPD N/A
- MKZR N/A
- P/E Ratio
- PYPD N/A
- MKZR N/A
- Revenue Growth
- PYPD N/A
- MKZR 57.39
- 52 Week Low
- PYPD $2.30
- MKZR $1.05
- 52 Week High
- PYPD $5.09
- MKZR $5.50
- Technical
- Relative Strength Index (RSI)
- PYPD 52.19
- MKZR N/A
- Support Level
- PYPD $2.65
- MKZR N/A
- Resistance Level
- PYPD $2.76
- MKZR N/A
- Average True Range (ATR)
- PYPD 0.10
- MKZR 0.00
- MACD
- PYPD 0.03
- MKZR 0.00
- Stochastic Oscillator
- PYPD 96.98
- MKZR 0.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.